U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.


U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.


Research shows the average American gains three to five pounds between Thanksgiving and New Year's Day. Although many people plan to lose that extra weight in the new year, too often that doesn't happen. That means after many years, a few extra pounds over the holidays adds up to what can be a serious weight problem, leading to a number of health issues including diabetes, cancer, and heart disease. 

Travelers wait in line to get tested for COVID-19 at Los Angeles International Airport in Los Angeles, Monday, Dec. 20, 2021.

President Biden rolls out his administration's newest strategy on Tuesday to battle the pandemic as the Omicron variant spreads rapidly across the country. 

In this April 13, 2021, file photo, a box of Johnson & Johnson vaccines are shown. (Szilard Koszticsak/MTI via AP, File)

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.

Theresa Zoller gets a rapid COVID-19 test from June Lopez, Dignity GoHealth medical assistant, before a United Airlines flight to Hawaii at San Francisco International Airport in San Francisco, Oct. 15, 2020. (AP Photo/Jeff Chiu)

The new omicron coronavirus mutant speeding around the world may bring another wave of chaos, threatening to further stretch hospital workers already struggling with a surge of delta cases and upend holiday plans for the second year in a row.

PAXLOVID, Pfizer's Anti-Viral COVID Pill. Photo Credit: Pfizer via AP, File

Pfizer says that its experimental COVID-19 pill appears effective against the omicron variant.

Image source: CBN News

The new Omicron variant of the coronavirus appears to cause less severe symptoms than earlier variants of COVID-19, but it's also more resistant to the Pfizer vaccine, according to two new studies. 


The United Kingdom is taking quick action to stop the spread of the omicron variant of the COVID-19 virus. 

Ariel Quero, 16, left, a student at Lehman High School, reacts after getting the Pfizer COVID-19 vaccine from Katrina Taormina, right, July 27, 2021, in New York.  (AP Photo/Mark Lennihan, file)

U.S. health authorities again expanded the nation's booster campaign Thursday, opening extra doses of Pfizer’s COVID-19 vaccine to several million 16- and 17-year-olds.